Authors

Mark Frydenberg

AM, MBBS, FRACS, Professor, Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic; Academic Director of Urology, Cabrini Research, Cabrini Health, Melbourne, Vic


Major changes with reduced harms in prostate cancer diagnosis and management

The advent of new technologies has turned the tide in the diagnosis and treatment of prostate cancer.


Prostate cancer

There is a need to support men to make informed decisions about prostate-specific antigen testing using appropriate information resources and decision aids.